Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis.
Infection
; 45(4): 539-543, 2017 Aug.
Article
em En
| MEDLINE
| ID: mdl-28577242
ABSTRACT
BACKGROUND:
Tumor necrosis factor α-inhibitors (TNFIs) have been associated with increased risk of certain fungal infections, including coccidioidomycosis. The optimal treatment approach to coccidioidomycosis in TNFI recipients is unknown.METHODS:
We constructed an anonymous, voluntary survey for practicing pulmonary and infectious disease physicians in the state of Arizona regarding approach to TNFI patients with coccidioidomycosis.RESULTS:
There is no current consensus on managing these patients.CONCLUSIONS:
Further research is necessary to determine the optimal approach to TNFI recipients with coccidioidomycosis.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fator de Necrose Tumoral alfa
/
Coccidioides
/
Coccidioidomicose
/
Assistência ao Paciente
/
Antifúngicos
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article